8 Best Neck Firming Creams To Use in Australia in 2025
These products are hand-picked by our team to help make shopping easier. We may receive payments from third parties for sharing this content and when you purchase through links in this article. Product prices and offer details are not assured, and should be confirmed independently with the retailer. Learn more
Turns out constantly staring at our phones – aka doomscrolling – is not only bad for our minds but also taking a toll on our physical appearance too.
Ever heard of the term 'tech neck'? Well now, you'll never forget it now.
Caused by the forward tilt of your head while continuously looking down at phone and computer screens, 'tech neck' leads to fine lines and creases across the neck that can be very annoying to get rid of.
And no, this isn't about ageing (which, by the way, is a privilege). But if you're looking to soften the appearance of those neck lines, we've rounded up a list of top-rated neck creams that are getting serious buzz.
Keep scrolling for our roundup of the most popular, most-reviewed neck creams you can get your hands on right now – including one from Trinny London that's the beauty entrepreneur's secret to a smoother and firmer neck.
OUR TOP PICKS
The Elevator, $128 at Trinny London
Trinny London The Elevator Neck Cream
Why we love it: It's a highly advanced formula to really target the appearance of fine lines and wrinkles on the delicate neck area.
What to consider: High price tag.
What You Need To Know
The best-selling neck cream from Trinny London is formulated with encapsulated alpha arbutin and a bunch of supercharged peptides to deeply hydrate the skin, brighten its appearance, and visibly soften fine lines for a smoother, plumper-looking neck.
But why does the neck show signs of ageing differently than the face?
We got to hear from Trinny London herself. 'It's because we have fewer things that support it to look younger. Our necks don't have as much fat underneath, which would normally make the skin look plumper. Our neck also doesn't have many sebaceous glands, which means it never gets oily and oiliness can be really good for skin to give it extra hydration,' she explained.
$96 at Adore Beauty
Why we love it: It's a rich, luxurious and creamy texture that feels great to put on.
What to consider: High price tag.
What You Need To Know
Ideal for those with mature, delicate and/or sun damaged skin, the Ella Bache Firming Neck Cream is a super rich treatment that's designed to really hydrate the skin.
It's formulated with a multi-active ingredient called Fabanine, which is a soy plant extract. After continued use, expect to see a more radiant neck area.
Five-star rating Adore Beauty shoppers have said this is a 'very hydrating and rich cream'.
'It has a very luxurious feel when patting in to neck and upper chest area. Wouldn't be without it,' said another happy user.
Why we love it: Universally loved by shoppers for its smooth texture and its results.
What to consider: High price tag.
What You Need To Know
One of Clarins' bestsellers has to be the Super Restorative Decollete and Neck Concentrate. It's packed with skin-loving ingredients like Harungana – something that's unique to the French beauty brand – to really replenish the delicate neck area and make it look more youthful and radiant.
It's racked up a very impressive average rating of 4.9 out of five on the Myer website, with rave reviews from shoppers noting it 'makes a visible difference in a short time'.
'It is a fantastic neck cream that is quickly absorbed and non-greasy,' said another five-star rating customer.
Natio Replenishing Neck and Decolettage Cream
$22.95 at Myer
Why we love it: Super budget-friendly option.
What to consider: May not feel as premium as other neck creams on our list.
What You Need To Know
You don't have to break the bank to get real results from a hardworking neck cream. This one from Natio will cost you under $25 and rave reviews from five-star rating Myer shoppers call it a 'miracle cream', praising it as an 'affordable product that gives results'.
Formulated with collagen-boosting plant peptides and antioxidant-rich bearberry extract, it works to even out skin tone, boost hydration, and leave the neck feeling noticeably softer and smoother.
Why we love it: Over time, this night cream will improve overall radiance of your face and neck.
What to consider: May be too powerful for super sensitive skin types.
What You Need To Know
If you're looking for an overall hardworking night cream that you can use on your face and your neck, this one from RoC Skincare is our top pick.
The formula is led by the ingredient that's had over seven years of research – the Hexyl-R complex – to really help you wake up with a totally renewed and radiant complexion.
Five-star rating iHerb shoppers say this cream 'works really well' and noting it makes a 'big difference' to the overall look of their skin.
Why we love it: This is double-duty day cream for your face and neck.
What to consider: Not suitable to be used at night time.
What You Need To Know
For those of us who want to really simplify our skincare routine, this day cream from No7 is a fabulous option as it combines the function of a cream for your face and neck in one.
Rave reviews from Priceline shoppers say their 'skin feels so much softer and looks brighter both on my face and neck.'
Another five-star reviewer said this is the 'best ever day cream'.
The formula is packed with ginseng extract to revitalise the skin, while antioxidants, peptides and vitamins help to protect the skin.
Finally a hydrating blend of Hibiscus peptides, hyaluronic acid and the brand's signature anti-wrinkle peptide technology is added to really hydrate the skin and help give it a visible glow.
$64 at Adore Beauty
Why we love it: Double-duty product to work for the delicate eye and neck area.
What to consider: High price tag for a small amount of product.
What You Need To Know
Adore Beauty shoppers say this double-duty cream from Skinstitut really works well to give you 'smooth and radiant' skin.
It's formulated with peptides and marine collagen to increase hydration and improve the overall tone and texture of the delicate skin around your eyes and neck.
The beauty brand have also added green coffee extract, avocado oil, aloe vera and ginseng to nourish the skin and give you a more glowy complexion.
The Jojoba Company Neck & Decolletage Lifting Concentrate
$64.95 at Adore Beauty
Why we love it: Offers more of a serum-feel that's super lightweight on the skin.
What to consider: Not a creamy texture like the other options on our list.
Formula: Serum | Size: 30ml | Key ingredient: Powerful botanicals
What You Need To Know
If you're looking for a lightweight treatment that feels more like a serum, rather than a cream, this pick from The Jojoba Company is a standout.
The Neck & Décolletage Lifting Concentrate offers an advanced formula to help boost collagen, replenish and hydrate the skin, and really help encourage a more youthful appearance.
The formula features ingredients specific to Australian beauty brand – Col-Frag 4, Gravityl and Liftylox – which all help to smooth the skin and improve overall radiance.
When choosing neck creams to include in our list, we evaluated several factors:
Price: Neck firming creams can sit at different price points, so you can pay as little as $22.95, with more pricier options sitting at about $155.
Formula: If you want a neck cream to work, it needs to be packed with powerful ingredients – think peptides, retinol, antioxidants and more hydrating, skin-loving actives,
Your skin type: Your skin type can determine what sort of skincare you should use – if you have dry skin, looking for extra hydrating ingredients. For those with sensitive skin, you're going to want to be careful with how many active products you load onto your skin. The skin on our neck can also be more delicate compared to the rest of our face.
HOW WE CHOOSE PRODUCTS
Our team of experienced writers spend hours researching products to include in articles. We find out what factors make a good product by talking to experts, reviewing test results and analysing thousands of customer reviews.
FREQUENTLY ASKED QUESTIONS
WHAT ELSE CAN YOU DO TO FIX TECH NECK?
Besides investing in a neck cream, if you want to keep a smooth and more youthful looking appearance, you're going to want to be applying an SPF every single morning.
The sun's UV rays contribute to all signs of ageing, so keeping your skin protected is key.
Another obvious point is not be on your phone as much – which we know, is not an easy task. Try and take regular breaks, and ensure you maintain good posture while scrolling and having fun with your friends.
WHAT'S THE BEST WAY TO APPLY A NECK CREAM?
For the best results, you should apply your neck cream everyday – think of it as an extension to the rest of your face. Make sure you always follow up with an SPF to keep your skin protected – you can see our roundup of the best ones for your face here.
Sign up to our weekly shopping newsletter to get the best deals, tips and guides delivered straight to your inbox.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
16 hours ago
- News.com.au
FDA Waiting Room: For Aussie applicants, it's (mainly) business as usual
Despite myriad pressures under the Trump regime, the FDA's drug and device approval process largely has been unfettered Telix Pharmaceuticals expects a company-making approval decision by the end of the month Painchek is among a string of device plays awaiting the agency's assent The US Food & Drug Administration's (FDA) resources have been cut more times than Martin Scorsese's then-edgy 1988 religious drama The Last Temptation of Christ. Word from within the powerful agency's imposing Maryland portals is that reviewers have struggled with their task of late because of lack of access to Zoom calls and similar everyday privations. For a legion of Australian drug and device makers awaiting company-making FDA approvals, it's a nervous time. But need they be worried? Business as usual In most cases, the risk of rejection is the same as being struck by lightning. The prevailing message is that despite mayhem at the agency in the Trump era, the approval process has not overly slowed unless the therapy is in a controversial realm (read: vaccines). Rather like the Kyiv denizens carrying out their lives amid a barrage of missiles, it's largely business as usual. A couple of notable rejections aside – namely Replimune Group's melanoma drug RP1, and see the Telix section below – so far this year the FDA has approved therapies for a range of cancers, autoimmune diseases, urinary tract infections and even menopausal hot flushes. PainChek (ASX:PCK) CEO Phil Daffas says the FDA does a 'superb' job under considerable pressure. The developer of a digital pain assessment, Painchek awaits FDA clearance under the de novo (new) device pathway (see below). 'Their M.O. (modus operandi) has been nothing but guidance and support,' he says. Aussie biotechs get the nod ASX life science have-a-go heroes have found favour, especially in the devices and diagnostics realm. In the drug space, the FDA last December greenlit Mesoblast's (ASX:MSB) graft-versus-host disease stem cell treatment, Ryoncil. In June, the agency approved CSL's (ASX:CSL) home-grown Andembry, the world's only prophylactic for hereditary angioedema. Device-wise, the agency approved Orthocell's (ASX:OCC) peripheral nerve repair tool Remplir. It also waved through EBR Systems' (ASX:EBR) groundbreaking left-ventricle assist device Wise and Nanosonics' (ASX:NAN) next-gen medical probe steriliser, Coris. 'Everyone was getting nervous towards the end, but we were very fortunate not to be impacted (by the FDA changes),' Nanosonics chief Michael Kavanagh says. 'The Australian medtech industry should be proud, not necessarily Nanosonics but Australia's ability to do these types of things.' Telix sweats on kidney imaging decision Is the FDA poised to make us further proud? Radiopharmacy giant Telix Pharmaceuticals (ASX:TLX) will know within three weeks whether the FDA has approved its kidney cancer imaging agent, Zircaix. The stakes could not be higher for the $6.8 billion market cap Telix, given Zircaix could well present a bigger market than for Illuccix, its approved prostate cancer imaging agent. So far at least, the FDA hasn't come back with any queries. Mind you, Telix hasn't had its way on other fronts. The FDA in late April knocked back the company's New Drug Application (NDA) for its brain cancer imaging agent, TLX101-CDx. As Telix CEO Dr Chris Behrenbruch pointedly noted, this was despite 'a robust consultation process prior to submission and during review of the NDA'. Painchek's painless process As with Telix, the FDA's decision will be company making for Painchek. Painchek's eponymous app is used across 110,000 nursing home beds in Australia, the UK and Canada – an addressable market of 500,000 beds. The US opens a market of three million beds, worth an estimated $100 million in annual recurring revenue. Painchek's FDA process started in 2019, when the company sought guidance on a supportive clinical trial (since successfully completed). 'The primary contact was the same person all the way through,' Daffas says. Painchek lodged its review in November 2024, after two pre-submission meetings with the agency. 'They recommended a two-step process, with feedback after each step,' he says. 'That was very helpful guidance. If there was room for a misunderstanding it got clarified in those two meetings.' Daffas says the FDA reps included experts in AI, privacy rules and cybersecurity and communications. 'Once again it's very helpful for us, as it makes for a more robust product.' Painchek expects an FDA decision around early October. 4D Medical breathes easy The developer of algo-based lung images tools, 4D Medical (ASX:4DX), has 'frequent flyer' status with the FDA which has approved eight of its devices already. These include its XV LVAS, which processes conventional X-ray scans 'to provide rich, functional lung health detail not available via other modalities'. 4D is now waiting to hear from the FDA about a ventilation perfusion imaging device. The company dubs the FDA's review as 'well progressed'. 4D has filed under the 510(k) predicate device route. According to the company, last year companies waited an average 112 days for an FDA yeah or nay. The current situation is 'aligning well with our experience in previous applications', the company says. Artrya is back for seconds … Artrya (ASX:AYA) says hard-to-detect coronary plaque is a key cause of heart attacks. This was an uncontroversial proposition for the FDA, which in late March approved Artrya's Salix Coronary Anatomy (SCA) platform. The AI-enabled tool provides point-of-care detection of high-risk plaque, a key predictor of heart attacks. Artrya has submitted for approval of a second device, Salix Coronary Plaque (SCP). SCP will extend the use to patients who have undergone a coronary CT angiogram. 'Once cleared, will enable us to deliver near real-time, AI-powered cardiac analysis to a large and growing market and unlock access to an established reimbursement code for plaque analysis,' co-founder (and now CEO) John Konstantopoulos says. The company expects to hear from the FDA by the end of September. … as is Echo IQ As with Artrya, heart diagnosis peer Echo IQ (ASX:EIQ) is no stranger to the FDA. In October last year the agency approved its EchoSolv AS, an AI-inspired device to detect aortic stenosis (narrowing of the heart valves). Echo IQ now is eyeing consent for a second product, EchoSolv HF, to detect heart problems early. It has teamed up with the esteemed Mayo Clinic to carry out a validation trial, the final requirement for FDA submission. Mayo also has exclusive rights to use EchoSolv HF across its 30 hospitals and possibly even co-brand the product. Echo IQ expects FDA approval by the end of the year. Imricor goes modular Still on matters of the heart, Imricor Medical Systems (ASX:IMR) is taking a Lego Masters approach to its maiden FDA application, for its cardiac ablation device, Vision-MR. By this we mean that Imricor has submitted its FDA in separate modules ('bricks'), to enable a rolling review. Vision-MR is the only ablation catheter designed for use with a magnetic resonance imaging (MRI) scanner, as opposed to x-ray fluoroscopy. The company last week said the second module was under review and it expects to submit the third module in the December quarter. 'We expect a steady string of 510(k) product submissions and approvals, which in turn helps accelerate the commercial launch across the US," the company says. In the March quarter European regulators re-approved Vision-MR, under tougher new rules. The European gatekeepers also approved Northstar, 'the world's only MRI-native 3D mapping and guidance system.' The FDA is also likely to approve Northstar in the current half. This will enable the company to start the initial rollout of its interventional cardiac magnetic resonance cardiac ablation labs. Patience, please Some applicants strike trouble with the FDA because they assume that reading the agency's intentions is easy as a Golden Book, when in fact they can be harder to fathom than Ulysses. As Telix's brain cancer setback attests, being on the same page is crucial. Amid the chaos of RFK Jr's early days as health czar, in March your columnist warned that while FDA approvals were often company making, don't expect quick returns. That's because shares may have run hard in anticipation of the happy event and profit takers move in. Often, companies raise capital on positive news and this constrains the share price. EBR did the rounds for $66 million in May and Mesoblast in January raised a monstrous $260 million. FDA approval is only the first step to commercialisation: securing reimbursement and distribution network are just as important. But without consent, companies aren't even in the starting block to tackle the world's richest – albeit more quixotic – healthcare market. If anyone needs reminding, the US accounts for roughly half of the world's healthcare expenditure.
ABC News
a day ago
- ABC News
How the United States found itself in a measles 'crisis'
There is a high risk the US will lose its measles elimination status — that's the stark warning from the country's health experts. The viral outbreak has led to broader questions over radical changes in vaccine policy under the leadership of Health Secretary Robert F Kennedy Jr. North America correspondent Kamin Gock reports.
News.com.au
a day ago
- News.com.au
Hidden health risks: What your bra could be doing to your body
You think that underwire is holding you up? Turns out it could be holding you back. Bras are pesky, uncomfortable, and — if you've got sensory issues like me — downright irritating. But it turns out they can be causing serious damage, too. Preventing you from breathing properly, standing tall, and even feeling calm. Yikes. From pinched nerves to posture problems, scientists and bra-fitters alike are spilling the boob tea. The wrong bra (and sometimes any bra) can be a total health saboteur. And yes, this includes the holy sports bra. Before you start a bonfire to burn all your bras for good, here's what can be causing issues, and how to fix them. First, let's address the urban legend. Bras do not cause breast cancer. There's evidence, including a population-based case-control study of postmenopausal women, found no link between bra wearing and cancer risk. That's regardless of underwire or hours worn. Now, strap in. Here's the ugly truth about what's lying under your T-shirt. Neck, shoulder and back pain Those trenches in your shoulders aren't just annoying, they're bad news. Deep grooves and red marks are signs your shoulders are carrying way too much weight. For women with a D-cup or larger, each breast can weigh 1.3kg or more. So, a bad fit turns into a literal load on your neck and spine, leading to poor posture, neck and back pain, tension headaches and long-term spinal misalignment. Clinical reports even cite narrow, tight straps from heavy-breasted women causing nerve and blood vessel compression in the clavicle area, a condition nicknamed 'bra strap syndrome.' Breathing and lymph flow restrictions Underwires and overly snug bands don't just squish your boobs. They can compress your rib cage, making it harder to breathe deeply, and can slow lymphatic drainage, the body's natural waste-removal system. Some experts also flag the use of nickel, latex, and BPA in bra materials as potential skin irritants and allergens. Anxiety and shallow breathing One lingerie designer warns that bra-induced shallow breathing can trigger the body's stress response, leaving you feeling tense without realising why. That tight band isn't just cutting off your comfort, it could literally be cutting into your calm. 'Wearing something that hurts or digs or reminds you all day long that your body doesn't fit the mould … and that takes a toll,' Bree McKeen told New York Post. 'The discomfort can be distracting, exhausting, even demoralising.' Worst offender: The underwire push-up It's the one most of us have owned at least once, and according to McKeen, it's the style doing the most damage. The underwire push-up bra pushes breast tissue into unnatural shapes, digs into delicate areas, compresses lymph pathways, and sets the stage for skin irritation and scarring. That perky lift could be costing you your long-term comfort. Even sports bras have a dark side Sure, they're great for high-impact workouts, but a University of Portsmouth study found overly restrictive sports bras can shift too much load to the spine, forcing back muscles to overcompensate. Over time, that can lead to serious back pain and strain. So, are there proven benefits to going braless? A 15-year French study tracked 330 women aged 18–35 and found those who went braless saw firmer, perkier breasts (around 7mm of nipple lift per year), better posture, deeper breathing, and less back pain. Sign, Me. Up. Researchers also suggested bras may weaken natural muscle support over time. Critics did point out the study's sample wasn't representative and factors like pregnancy weren't accounted for. But it still challenges the long-held belief that constant strapping equals better support. Now, for the large-bust crew reading this, I'm sure you're rolling your eyes. And your scepticism is valid. If your daily reality includes heavier breasts pulling your spine into a permanent hunch, going braless might sound like a sick joke. Here's the nuance: Support can help initially: If you've relied on bras for decades, quitting cold turkey may worsen posture or pain at first. Experts recommend gradually reducing wear while strengthening upper-back and chest muscles. Fit is everything: Around 80–85 per cent of women wear the wrong bra size, which means the band rides up your back, straps do all the heavy lifting, and pain piles on. Better strap design matters: Wide, vertical straps (around 4.5 cm) or gel-padded options have been shown to reduce shoulder pressure during activity. So … do you torch all of your bras now? Not necessarily. The villain is bad fit and over-reliance, not every bra ever made. Choose breathable fabrics, adjustable straps, and proper measurements. If you're feeling up to it, go braless when you can. especially at home.
